AEPCX | FCADX | AEPCX / FCADX | |
Total Expense Ratio | 1.57 | 1.62 | 97% |
Annual Report Gross Expense Ratio | 1.57 | 1.62 | 97% |
Fund Existence | 24 years | 21 years | - |
Gain YTD | 11.554 | 17.017 | 68% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 133B | 11.3B | 1,177% |
Annual Yield % from dividends | 0.17 | 1.55 | 11% |
Returns for 1 year | 1.01 | 9.73 | 10% |
Returns for 3 years | 27.65 | 49.46 | 56% |
Returns for 5 years | 9.28 | 25.12 | 37% |
Returns for 10 years | 17.78 | 36.49 | 49% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KDEF | 41.14 | 1.16 | +2.90% |
Plus Korea Defense Industry Index ETF | |||
DGIN | 43.55 | 0.36 | +0.84% |
VanEck Digital India ETF | |||
IWMY | 23.97 | 0.20 | +0.84% |
Defiance R2000 Target 30 Income ETF | |||
HQL | 13.05 | 0.09 | +0.69% |
abrdn Life Sciences Investors | |||
GRID | 139.46 | 0.63 | +0.45% |
First Trust NASDAQ® Cln Edge®StGidIfsETF |